Search Results - "Sahara, Shu"

Refine Results
  1. 1

    Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer by Sugimoto, Mitsushige, Ban, Hiromitsu, Ichikawa, Hitomi, Sahara, Shu, Otsuka, Taketo, Inatomi, Osamu, Bamba, Shigeki, Furuta, Takahisa, Andoh, Akira

    Published in Internal Medicine (01-01-2017)
    “…Objective The Kyoto gastritis classification categorizes the endoscopic characteristics of Helicobacter pylori (H. pylori) infection-associated gastritis and…”
    Get full text
    Journal Article
  2. 2

    Efficacy of Tailored Helicobacter pylori Eradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion by Sugimoto, Mitsushige, Uotani, Takahiro, Sahara, Shu, Ichikawa, Hitomi, Yamade, Mihoko, Sugimoto, Ken, Furuta, Takahisa

    Published in Helicobacter (Cambridge, Mass.) (01-08-2014)
    “…Background Insufficient acid inhibition during Helicobacter pylori eradication treatment and bacterial resistance to antibiotics often causes eradication…”
    Get full text
    Journal Article
  3. 3

    Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis by Sahara, Shu, Sugimoto, Mitsushige, Vilaichone, Ratha-Korn, Mahachai, Varocha, Miyajima, Hiroaki, Furuta, Takahisa, Yamaoka, Yoshio

    Published in BMC infectious diseases (21-09-2012)
    “…Infection with cagA-positive, cagA EPIYA motif ABD type, and vacA s1, m1, and i1 genotype strains of Helicobacter pylori is associated with an exacerbated…”
    Get full text
    Journal Article
  4. 4

    Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients by Sakao, Yukitoshi, Ohashi, Naro, Sugimoto, Mitsushige, Ichikawa, Hitomi, Sahara, Shu, Tsuji, Takayuki, Kato, Akihiko, Fujigaki, Yoshihide, Sugimoto, Ken, Furuta, Takahisa, Yasuda, Hideo

    Published in Therapeutic apheresis and dialysis (01-02-2019)
    “…Ghrelin is an orexigenic hormone mainly secreted by the stomach, and it decreases according to the severity of gastric atrophy. Ghrelin has multiple favorable…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients by Ichikawa, Hitomi, Sugimoto, Mitsushige, Sakao, Yukitoshi, Sahara, Shu, Ohashi, Naro, Kato, Akihiko, Sugimoto, Ken, Furuta, Takahisa, Andoh, Akira, Sakao, Tadashi, Yasuda, Hideo

    Published in World journal of gastroenterology : WJG (21-12-2016)
    “…AIM To investigate the relationship between plasma ghrelin level, Helicobacter pylori(H. pylori) infection status and the severity of atrophy in hemodialysis…”
    Get full text
    Journal Article
  7. 7

    Eradication of H. pylori Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin by Furuta, Takahisa, Sugimoto, Mitsushige, Yamade, Mihoko, Uotani, Takahiro, Sahara, Shu, Ichikawa, Hitomi, Kagami, Takuma, Yamada, Takanori, Osawa, Satoshi, Sugimoto, Ken, Watanabe, Hiroshi, Umemura, Kazuo

    Published in Internal Medicine (01-01-2014)
    “…Eradication of H. pylori in patients allergic to penicillin should be performed using regimens without penicillin derivatives. We treated a total of 28…”
    Get full text
    Journal Article
  8. 8

    Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan by Furuta, Takahisa, Sugimoto, Mitsushige, Kodaira, Chise, Nishino, Masafumi, Yamade, Mihoko, Uotani, Takahiro, Sahara, Shu, Ichikawa, Hitomi, Yamada, Takanori, Osawa, Satoshi, Sugimoto, Ken, Watanabe, Hiroshi, Umemura, Kazuo

    Published in Journal of gastroenterology and hepatology (01-03-2014)
    “…s Backgrounds Quinolone‐based regimens have been used as the rescue for eradication of Helicobacter pylori. Sitafloxacin is known to have low minimum…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Natural Course of Helicobacter pylori Infection in Japanese Hemodialysis Patients by Sugimoto, Mitsushige, Sahara, Shu, Ichikawa, Hitomi, Sakao, Yukitoshi, Ohashi, Naro, Sugimoto, Ken, Yasuda, Hideo, Furuta, Takahisa, Andoh, Akira

    Published in Digestion (01-01-2017)
    “…Helicobacter pylori (H. pylori) infection is one of the major risk factors for gastrointestinal morbidity in hemodialysis patients. Primary end point is to…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Potent Gastric Acid Inhibition Over 24 Hours by 4-Times Daily Dosing of Esomeprazole 20 mg by Sahara, Shu, Sugimoto, Mitsushige, Uotani, Takahiro, Ichikawa, Hitomi, Yamade, Mihoko, Kagami, Takuma, Hamaya, Yasushi, Iwaizumi, Moriya, Osawa, Satoshi, Sugimoto, Ken, Miyajima, Hiroaki, Furuta, Takahisa

    Published in Digestion (01-01-2015)
    “…When administered at a standard dose, proton pump inhibitors (PPIs) do not always provide sufficient acid inhibition for all subjects, particularly in…”
    Get more information
    Journal Article
  14. 14

    Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients by Sakao, Yukitoshi, Sugimoto, Mitsushige, Ichikawa, Hitomi, Sahara, Shu, Tsuji, Takayuki, Ohashi, Naro, Kato, Akihiko, Fujigaki, Yoshihide, Sugimoto, Ken, Furuta, Takahisa, Sakao, Tadashi, Yasuda, Hideo

    Published in American journal of nephrology (01-09-2016)
    “…Ghrelin, an orexigenic hormone, has multiple favorable functions including protein anabolism enhancement, anti-inflammatory actions, and cardiovascular…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Primary synovial sarcoma of the stomach—A case report and review of the literature by Sahara, Shu, Otsuki, Yoshiro, Egawa, Yuki, Shimizu, Shin-ichi, Yoshizawa, Yashiro, Hosoda, Yoshisuke, Suzuki, Kazufumi, Sato, Yoshihiko, Kobayashi, Hiroshi

    Published in Pathology, research and practice (01-11-2013)
    “…Synovial sarcoma (SS) is a mesenchymal spindle cell tumor which displays variable epithelial differentiation. It commonly arises around the major joints or…”
    Get full text
    Journal Article
  19. 19

    Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine by Uotani, Takahiro, Sugimoto, Mitsushige, Nishino, Masafumi, Ichikawa, Hitomi, Sahara, Shu, Yamade, Mihoko, Iwaizumi, Moriya, Yamada, Takanori, Osawa, Satoshi, Sugimoto, Ken, Umemura, Kazuo, Watanabe, Hiroshi, Miyajima, Hiroaki, Furuta, Takahisa

    Published in Journal of clinical pharmacology (01-08-2014)
    “…Anti‐platelet drug‐induced gastric mucosal injury correlates with intragastric pH. Our aim was to investigate prophylaxis effects of famotidine, one of the…”
    Get full text
    Journal Article
  20. 20

    Antiplatelet drugs are a risk factor for esophageal mucosal injury by Sugimoto, Mitsushige, Uotani, Takahiro, Nishino, Masafumi, Yamade, Mihoko, Sahara, Shu, Yamada, Takanori, Osawa, Satoshi, Sugimoto, Ken, Umemura, Kazuo, Watanabe, Hiroshi, Miyajima, Hiroaki, Furuta, Takahisa

    Published in Digestion (01-01-2013)
    “…In esophagus whether antiplatelet drugs, such as low-dose aspirin (LDA) and clopidogrel, induce mucosal injury by pH changes or by acid reflux is unclear. We…”
    Get more information
    Journal Article